Clinical Trials Browser

Completed × NETWORK × siltuximab × Clear all

NCT00433446 2013-02-05

S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

62 enrolled 13 charts

Prostatic Neoplasms